FDA Inspection 1203642 — Scott A. Smith D.O.
The FDA completed an inspection of Scott A. Smith D.O. on March 22, 2023 in Spokane Valley, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 22, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Spokane Valley, WA (United States)
Additional Details
Clinical Investigator (CI)